METHOD OF MANUFACTURING TRANSDERMAL ABSORPTION SHEET AND TRANSDERMAL ABSORPTION SHEET

• US 20170057124A1
• Filed: 11/14/2016
• Published: 03/02/2017
• Est. Priority Date: 05/15/2014
• Status: Abandoned Application

• Current Assignee: Fujifilm Corporation (Fujifilm Holdings Corporation)
• Original Assignee: Fujifilm Corporation (Fujifilm Holdings Corporation)
• Inventors: WAKAMATSU, Satoshi, KABATA, Koki
• Application Number:
  US15/350,753
• Publication Number:
  US 20170057124A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61K 38/385 Serum albumin
• CPC Class Codes: A61K 47/36 Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• CPC Class Codes: A61K 9/703 characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
• CPC Class Codes: A61M 2037/0023 Drug applicators using microneedles
• CPC Class Codes: A61M 2037/0046 Solid microneedles
• CPC Class Codes: A61M 2037/0053 Methods for producing microneedles
• CPC Class Codes: A61M 37/00 Other apparatus for introducing media into the body for reproduction or fertilisation A61B17/425; apparatus for iontophoresis or cataphoresis A61N1/30; Percutany, i.e. introducing medicines into the body by diffusion through the skin salt baths A61H33/04
• CPC Class Codes: A61M 37/0015 by using microneedles
• CPC Class Codes: B29C 39/025 for making multilayered articles
• CPC Class Codes: B29K 2467/003 PET, i.e. polyethylene terephthalate
• CPC Class Codes: B29K 2883/00 Use of polymers having silicon, with or without sulfur, nitrogen, oxygen, or carbon only, in the main chain, as mould material
• CPC Class Codes: B29K 2995/0056 Biocompatible, e.g. biopolymers or bioelastomers
• CPC Class Codes: B29L 2031/753 Medical equipment; Accessories therefor bloodbags, medical bags B29L2031/7148; artificial eyes B29L2011/0008

Abstract

An object is to provide a method of manufacturing a transdermal absorption sheet and a transdermal absorption sheet that can suppress generation of air bubbles. In the method of manufacturing the transdermal absorption sheet that includes a drug solution filling step, a drug solution drying step, a base solution filling step, a base solution drying step, and a peeling-off step in that order, each step of at least from the drug solution filling step to the base solution drying step is performed in an environment with a temperature of 1° C. to 10° C.

Claims

1. A method of manufacturing a transdermal absorption sheet comprising, in this order:

a drug solution filling step of filling needle-shaped recesses of a mold, the needle-shaped recesses being arranged two-dimensionally, with a drug solution that is a polymer solution containing a predetermined amount of a drug;

a drug solution drying step of drying the drug solution filled in the needle-shaped recesses to form a first layer containing a predetermined amount of a drug;

a base solution filling step of filling the needle-shaped recesses on the first layer with a base solution that is a polymer solution not containing a predetermined amount of a drug;

a base solution drying step of drying the base solution to form a second layer not containing a predetermined amount of a drug on the first layer; and

a peeling-off step of peeling off the first layer and the second layer from the mold,

wherein each step of at least from the drug solution filling step to the base solution drying step is performed in an environment with a temperature of 1°

C. to 10°

C.

2. The method of manufacturing a transdermal absorption sheet according to claim 1,

wherein at least one step of the drug solution drying step and the base solution drying step is performed in an environment with a relative humidity of 1% RH to 59% RH.

3. The method of manufacturing a transdermal absorption sheet according to claim 1, further comprising

at least one of a step of deaerating the drug solution before the drug solution filling step and a step of deaerating the base solution before the base solution filling step.

4. The method of manufacturing a transdermal absorption sheet according to claim 1,

wherein the needle-shaped recess of the mold has a through hole at a tip end thereof.

5. The method of manufacturing a transdermal absorption sheet according to claim 1,

wherein in the drug solution drying step, the drying is performed in a calm state.

6. The method of manufacturing a transdermal absorption sheet according to claim 1,

wherein in the drug solution filling step, a nozzle that discharges the drug solution is scanned on the mold in a state where the nozzle is pressed to the mold, and the needle-shaped recesses are filled with the drug solution from the nozzle while a pressing force of the nozzle to the mold is controlled.

7. The method of manufacturing a transdermal absorption sheet according to claim 1,

wherein in the drug solution filling step, a nozzle that discharges the drug solution is scanned on the mold in a state where the nozzle is pressed to the mold, and the needle-shaped recesses are filled with the drug solution from the nozzle while a push-in distance of the nozzle to the mold is controlled.

8. The method of manufacturing a transdermal absorption sheet according to claim 1,

wherein in the drug solution filling step, the amount of the drug solution to be filled is equal to a total volume of the needle-shaped recesses.

9. The transdermal absorption sheet according to claim 1,

wherein the drug is a peptide, a protein, a nucleic acid, a polysaccharide, a vaccine, a medical compound belonging to a water-soluble low-molecular compound, or a cosmetic component.

10. A transdermal absorption sheet manufactured by the method of manufacturing the transdermal absorption sheet according to claim 1.